Cancer is a group of diseases (over 100 types) involving abnormal cell growth with the potential to invade or spread to other different tissues. Today the problem of cancer is actual and needs a lot of efforts to solve it. OTAVAchemicals offers Cancer Targeted Libraries designed with Ligand-based and Receptor-based approach. These libraries are proposed for screening in cancer-associated research and drug development projects.

Hundreds millions of people have diabetes worldwide. Diabetes is estimated to have resulted in 1.5 to 5.0 million deaths each year. Today researchers are making a lot of efforts to develop new, more effective compounds to treat this disease. OTAVAchemicals offers Diabetes Targeted Libraries designed with Ligand-based and Receptor-based approach. These libraries are proposed for screening in diabetes-associated research and drug development projects.

During the past decades, several agents have been approved that enhance cognition of Alzheimer's disease (AD) patients. However, the effectiveness of these treatments are limited or controversial and they do not modify disease progression. Recent advances in understanding AD pathogenesis have led to the development of numerous compounds that might modify the disease process. Taking into account AD complexity, it becomes clear that polypharmacology with drugs targeting different sites could be the future treatment approach and a majority of the recent drugs under evaluation seems to act on multiple targets.